Mukka Proteins (MUKKA) | Stock Overview & Key Data
Mukka Proteins Performance Comparison
Stock Range
Today's Range
Low: ₹27.42
High: ₹28.13
on August 13, 2025
52 Week Range
Low: ₹24.75
High: ₹51.85
on August 7, 2025
on August 20, 2024
All-Time High: ₹56.56 on July 15, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR8.2B
EPS
1.55
P/E Ratio (TTM)
17.54
Forward P/E
N/A
P/B Ratio
1.86
PEG Ratio
N/A
Div. Yield
N/A
ROE
11.12%
Beta
N/A
Debt to Equity
99.21
Financial Highlights
Profitability
Gross Margin
16.21%
Operating Margin
6.91%
Profit Margin
4.62%
Returns and Earnings
Return on Assets (TTM)
5.04%
Return on Equity (TTM)
11.12%
EBITDA
INR1.1B
Net Income (TTM)
INR464.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR33.55
Quarterly Revenue Growth (YoY)
47.50%
Quarterly Earnings Growth (YoY)
-50.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Mukka Proteins MUKKA | 8.20B Small-cap | -1.54% | -7.40% | -11.97% | -21.81% | -32.30% | -41.22% | -36.07% | -36.07% |
| Nestle India NESTLEIND | 2.12T Large-cap | -3.75% | -8.81% | -8.46% | -0.53% | 0.60% | -13.59% | 12.25% | 31.76% |
| Britannia Industries BRITANNIA | 1.30T Large-cap | -5.28% | -7.62% | -4.82% | 8.53% | 11.33% | -6.84% | 45.75% | 37.48% |
| Gujarat Ambuja GAEL | 47.15B Small-cap | -1.83% | -6.23% | -11.62% | -9.39% | -17.42% | -19.63% | -27.71% | 119.25% |
| Gopal Snacks GOPAL | 44.17B Small-cap | 1.99% | 3.10% | 28.65% | 17.32% | 0.21% | 8.36% | -4.29% | -4.29% |
| Gokul Agro Resources GOKULAGRO | 43.87B Small-cap | 4.58% | 0.66% | 30.33% | 5.46% | -13.92% | 46.45% | 274.10% | 1,976.92% |
Ownership & Short Interest
Insider Ownership
77.63%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
261K
Average 90-Day Volume
253K
Mukka Proteins Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Mukka Proteins would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MUKKA's 52-week high and low?
- In the last 52 weeks, Mukka Proteins reached a high of ₹51.85 (on August 20, 2024) and a low of ₹24.75 (on August 7, 2025).
- What is the market cap and P/E ratio for MUKKA?
- Curious about Mukka Proteins's size and valuation? Its market capitalization stands at 8.20B. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.54, and the forward P/E (looking ahead) is N/A.
- Does MUKKA pay dividends? If so, what's the yield?
- As for dividends, Mukka Proteins isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Mukka Proteins's main competitors or similar companies to consider before investing?
When looking at Mukka Proteins, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Nestle India
NESTLEIND2.12T Consumer Defensive Packaged Foods -13.59% 12.25% Britannia Industries
BRITANNIA1.30T Consumer Defensive Packaged Foods -6.84% 45.75% Gujarat Ambuja
GAEL47.15B Consumer Defensive Packaged Foods -19.63% -27.71% Gopal Snacks
GOPAL44.17B Consumer Defensive Packaged Foods 8.36% -4.29% Gokul Agro Resources
GOKULAGRO43.87B Consumer Defensive Packaged Foods 46.45% 274.10% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Mukka Proteins Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Mukka Proteins's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.12%, the Debt to Equity ratio from the most recent quarter is 99.21, and its Gross Profit Margin stands at 16.21%.
- What is the recent revenue and earnings growth for MUKKA?
- Looking at Mukka Proteins's growth, its revenue over the trailing twelve months (TTM) was INR10B. Compared to the same quarter last year (YoY), quarterly revenue grew by 47.50%, and quarterly earnings saw a YoY growth of -50.00%.
- How much of MUKKA stock is held by insiders and institutions?
- Wondering who owns Mukka Proteins stock? Company insiders (like executives and directors) hold about 77.63% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.